Tag: haemodialysis

bloodline

Fresenius Medical Care North America introduces first single-use integrated bloodline to...

Fresenius Medical Care North America's (FMCNA) Renal Therapies Group recently announced the availability of the CombiSet Smartech. According to a company press release, this...

Intraoperative vascular mapping during haemodialysis access “should be incorporated into routine...

Intraoperative ultrasonographic venous mapping is a useful tool to evaluate vessel suitability for arteriovenous fistula (AVF) creation, Yana Etkin (Zucker School of Medicine at...

First patient enrolled in Merit Medical’s WRAPSODY registry study

Merit Medical has announced the successful enrolment of the first patient in its WRAP registry study in a press release. This study will evaluate...

Air pollution exposure may heighten risk of heart disease among US...

In a retrospective cohort study published in the American Journal of Kidney Diseases (AJKD), researchers have found that US adults receiving haemodialysis who are exposed...

Outset Medical announces shipment hold on new Tablo haemodialysis systems for...

Outset Medical today announced it has implemented a shipment hold on the distribution of its Tablo haemodialysis system for home use pending the US...
Flex Vessel Prep

VentureMed completes enrolment of Flex Vessel Prep system randomised controlled trial...

VentureMed Group recently announced that it has completed enrolment of a randomised controlled trial (RCT) titled 'Flex Vessel Prep prior to PTA for the...

Nipro introduces Surdial Dx haemodialysis system to US market

Nipro Medical Corporation has announced the commercial launch of its Surdial Dx haemodialysis system—designed to create an optimal dialysis treatment experience for patients and...

Diality closes US$24 million funding round to support development of haemodialysis...

Diality has announced the close of a US$24 million Series B2 investment round. The Series B2 round of funding will be used for activities to support...

Houston, we have a dialysis access problem

The concept of dedicated vascular access centres fuels a turbocharged Texan tussle with Karl Illig (Flow Vascular Center, Houston, USA) taking on Eric Peden...

Humacyte announces publication of positive long-term follow-up data from phase 2...

Humacyte today announced that five-year data from a phase 2 clinical trial of patients receiving the investigational Human Acellular Vessel (HAV) for arteriovenous (AV)...
haemodialysis patients cannulation

Systematic review sheds light on “unpleasant necessity” of cannulation for haemodialysis...

A systematic review published in the Journal of Vascular Access (JVA) has illuminated haemodialysis patients’ views and experiences of arteriovenous access cannulation, concluding that...

Dialyss Pte Limited acquired by NextKidney BV

NextKidney BV has announced the acquisition of Dialyss Pte Limited from 1 January 2022. According to a press release, this marks a major milestone...

Zynex announces first enrolment in haemodialysis clinical trial of fluid monitoring...

Zynex Monitoring Solutions recently reported it has started enrolment in a haemodialysis clinical trial with its CM-1500 fluid monitoring system. The study, conducted at...
magic cannulation technique

Early data indicate benefits of MAGIC in improving cannulation technique

Early data have indicated that a national project, dubbed MAGIC (Managing access by generating improvements in cannulation), has improved cannulation techniques of haemodialysis accesses...
vascular access handbook gemav

New vascular access handbook intends to provide dialysis patients with answers...

At the 12th Congress of the Vascular Access Society (VAS; 6–9 April 2021, online), Ramon Roca-Tey, senior consultant in nephrology at the Fundación Sanitaria...

Outset Medical gains landmark CMS approval for Tablo home haemodialysis system

Outset Medical has announced that its Tablo haemodialysis system has received the first ever approval from the Centers for Medicare & Medicaid Services (CMS) for...

New survey finds one third of UK dialysis patients still not...

Quanta Dialysis Technologies announced today the results of the UK Dialysis Patient Experience Survey, showing the wide variance in care experienced by UK dialysis...

Bluegrass Vascular announces Medicare decision to assign New Technology Ambulatory Payment...

Bluegrass Vascular Technologies (Bluegrass Vascular) announced today that the Centers for Medicare & Medicaid Services (CMS) has finalised a new Healthcare Common Procedure Coding...

DCBs favoured over PTA for treatment of dysfunctional haemodialysis venous access

A patient-level meta-analysis of randomised controlled trials (RCTs) has shown that drug-coated balloons (DCBs) were “consistently favoured” over percutaneous transluminal angioplasty (PTA) to prolong...
home haemodialysis failure

Significant mortality increase seen after home haemodialysis failure compared to continued...

Failure of home haemodialysis (HHD) treatment, defined as a return to in-centre haemodialysis (ICHD), has been associated with a “significant increase” in mortality when...
amplifi vein dilation system

Artio Medical completes enrolment of first-in-human trial investigating Amplifi vein dilation...

Artio Medical announced today it has completed enrolment in its first-in-human study evaluating the Amplifi vein dilation system. In the study, five patients were treated...
covid-19 vaccine dialysis patients

Nationwide survey indicates hesitancy among US dialysis patient groups over COVID-19...

A nationwide survey distributed among 150 randomly selected dialysis facilities in the USA has found that a “substantial proportion” of patients receiving in-centre haemodialysis...
PROPr kidney failure score

New scoring system measures health-related quality of life in kidney failure...

Results from a new study support the validity of a score that considers various patient-reported measures and preferences for assessing health-related quality of life,...
quanta dialysis funding

Quanta announces “largest private funding round in history” for a dialysis...

Quanta Dialysis Technologies has announced that it has raised US$245 million in an oversubscribed and upsized Series D financing round—the largest private funding round...
covid-19 vaccine dialysis patients

US Renal Care distributes second round of COVID-19 vaccines to dialysis...

Dialysis provider US Renal Care recently announced it has finished administering a second round of mRNA vaccines to ensure better protection against COVID-19 for...

Arteriovenous fistulas contribute to higher survival of haemodialysis patients with COVID-19

A new study, published online in The Journal of Vascular Access (JVA), suggests that arteriovenous fistulas (AVFs) contribute to higher survival of haemodialysis patients...
theranova dialyser

Baxter reports Theranova dialyser may reduce cardiovascular events and hospitalisations

Baxter International, a global innovator in renal care, has announced new data showing expanded haemodialysis (HDx) therapy enabled by the company's Theranova dialyser may...
Robert Jones in the IR suite

Balloon angioplasty in critical time window central to endovascular success for...

Tackling the main culprit, stenosis in the arteriovenous anastomosis and outflow veins, with balloon angioplasty before it is “too late” can boost maturation rates...
era congress 2021

ERA-EDTA announces name change following late-breaking clinical data at 2021 congress

Fresh evidence on the usefulness of sonography to ease the burden of lung congestion in haemodialysis patients and “promising data” on a long-awaited targeted...
new vascular access technologies

Nitric oxide, simulation and “living” grafts: Is the landscape of vascular...

The field of vascular access care for haemodialysis patients may look very different in just a few years’ time, with a host of new,...
early-cannulation grafts

Early-cannulation grafts display parity with ePTFE options—but also face similar challenges

In addition to demonstrating comparable performance in terms of long-term patency, durability and associated complications, early-cannulation arteriovenous (AV) grafts may hold some advantages when...
baxter international artificial kidney ak 98 dialysis machine

Baxter gains FDA clearance for next-generation AK 98 dialysis machine

American healthcare firm and global renal care innovator Baxter International has announced US Food and Drug Administration (FDA) 510(k) clearance of its next-generation Artificial...

Study supports tunnelled haemodialysis catheter use for permanent dialysis access

In a recent study, Victor Demaerel (University Hospitals Leuven, Leuven, Belgium) and colleagues found that tunnelled haemodialysis catheter (THC) survival in 352 patients was...
sabine nipshagen plastic cannulas

Plastic cannulas offer useful new option in toolbox for renal nurses

Despite currently being less commonly used than metal needles in haemodialysis access, particularly in Europe, plastic cannulas offer a “useful new tool in the...
invizius

Invizius raises £5.3 million to assess anti-inflammatory treatment for haemodialysis patients

Invizius has announced the closing of a Series A financing round worth £5.3 million. The Scottish biotechnology company will use this funding to complete...

Vascular Therapies announces clinical results from phase 3 randomised multicentre clinical...

Vascular Therapies recently announced results from its phase 3 clinical trial in which Sirogen showed encouraging arteriovenous fistula (AVF) outcomes in elderly end-stage renal...

BD announces enrolment in postmarket studies of the WavelinQ endoAVF system

BD announced today that enrolment has begun and the first patients have been treated in the postmarket surveillance study, CONNECT-AV. CONNECT-AV is a prospective, single-arm,...
haemodialysis access spontaneous recanalisation ansar vance

Clotted haemodialysis accesses can spontaneously recanalise following abandonment

Clotted haemodialysis accesses can spontaneously recanalise following a failed thrombectomy and subsequent abandonment, a retrospective review of 3,137 mechanical thrombectomy procedures has found. The...
pristine catheter bd

BD gains FDA 510(k) clearance for Pristine long-term haemodialysis catheter

American medical technology company BD (Becton, Dickinson and Company) has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Pristine...
haemodialysis access strategies mariana murea nephrology professor

Multicentre trial of haemodialysis access strategies in older patients deemed feasible...

A multicentre clinical trial to assess arteriovenous fistula (AVF)-first and arteriovenous graft (AVG)-first access strategies in older end-stage renal disease (ESRD) patients on haemodialysis...

Fresenius and DaVita make home dialysis technologies available to patients across...

Fresenius Medical Care North America and DaVita Kidney Care have announced an expanded agreement to make multiple home dialysis technologies available for patients across...

ISABELLA trial for the treatment of failing AV fistulas in haemodialysis...

MedAlliance has announced completion of patient enrolment in the ISABELLA clinical trial with the Selution SLR 018 drug-eluting balloon (DEB) for the treatment of...

Tunneled cuffed dialysis catheters: Why does the catheter’s tip matter?

A tunneled catheter remains the most common access in patients initiating haemodialysis.1 This is most likely because the catheters are ready to use immediately...

PatenSee initiates first-in-human trial with its contactless imaging surveillance system for...

PatenSee has initiated a first-in-human clinical trial to assess its machine vision-based surveillance system, a press release from the company reveals. The trial, led...

Medtronic launches IN.PACT AV DCB in Japan for patients undergoing haemodialysis

Medtronic has announced the launch of IN.PACT AV drug-coated balloon (DCB) in Japan. IN.PACT AV DCB is indicated for the treatment of obstructive lesions...